Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Acetyl-Carnitine and Reduced Neuropathic Pain

Research synthesisLow evidenceModerate effect3 studies · 2 beneficial · 1 neutral · 0 harmful

Across 3 studies, 2 reported beneficial effects of acetyl-carnitine on neuropathic pain, with moderate effect sizes in clinical populations. One systematic review found neutral results for magnesium and St. John's wort but did not specifically isolate acetyl-carnitine effects. The median study duration was 56 days, suggesting effects may be observed at around 8 weeks. No consistent dose or form was identified across studies.

  • Studied populations: patients with acute low back trauma; patients with peripheral neuropathies

Caveats: Evidence base is small (only 3 studies) — conclusions should be considered preliminary. One systematic review (2024) that found neutral effects did not appear to isolate acetyl-carnitine as a primary intervention, instead grouping it with other supplements for mixed neuropathologies. Both beneficial studies are recent and may reflect emerging but unconfirmed findings.

Generated Jun 12, 2026
Time to effect
Median: 8 weeks · IQR 8 weeks8 weeks · Range 8 weeks8 weeks — Reported in 1 of 3 studies
Safety in these studies
3 of 3 papers
Back to top